Get a glimpse into our company and investor data—powered by the PitchBook Platform
Series ALATEST DEAL TYPE
$4.5MLATEST DEAL AMOUNT
Operator of a clinical genetics laboratory. The company provides a feasibility study of cell-based non-invasive prenatal screening, demonstrating a successful prenatal screening protocol that allows analysis of an intact fetal genome.